Kaneka Corp
TSE:4118
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (3.6), the stock would be worth ¥4 260.82 (11% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4 | ¥4 812 |
0%
|
| 3-Year Average | 3.6 | ¥4 260.82 |
-11%
|
| 5-Year Average | 3.5 | ¥4 215.85 |
-12%
|
| Industry Average | 7.1 | ¥8 433.99 |
+75%
|
| Country Average | 8.7 | ¥10 311.85 |
+114%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥336.6B
|
/ |
Jan 2026
¥77.8B
|
= |
|
|
¥336.6B
|
/ |
Mar 2026
¥84.6B
|
= |
|
|
¥336.6B
|
/ |
Mar 2027
¥90.3B
|
= |
|
|
¥336.6B
|
/ |
Mar 2028
¥99.8B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Kaneka Corp
TSE:4118
|
293B JPY | 4 | 11.3 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 11.1 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | -84.7 | 41.8 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
532T IDR | -59.5 | 28.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
27.6B USD | 13.6 | -10.5 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
169.8B CNY | 18.4 | 19 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
22.8B USD | 14.3 | -30.3 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
675.7B TWD | 28.4 | 149.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
30.6T KRW | 7 | -16.8 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
118.8B CNY | 28.7 | 161.3 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
100.5B CNY | 57.6 | 73.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
Kaneka Corp
Glance View
In the sprawling landscape of Japanese industry, Kaneka Corporation stands out with its diversified portfolio that stretches across numerous sectors. Founded in 1949, originally part of a chemical industry boom in post-war Japan, Kaneka has artfully knitted its presence into various essential markets. The company initially made its mark in the chemical sector, producing vinyl chloride and other essential materials. Over the decades, it has leveraged its expertise in chemical engineering to expand into areas like foodstuffs, pharmaceuticals, and electronic materials. Each division, meticulously carved out from its core competencies, serves as a pillar in its robust business model. From developing high-performance polymers to innovative biotechnological solutions, Kaneka continuously adapts to meet the evolving demands of modern society. Kaneka's business prowess lies in its ability to integrate innovation with tangible applications. For instance, in the health and nutrition sector, the company thrives with a wide variety of products ranging from functional foods to dietary supplements, catering to a global market increasingly conscious of wellness and longevity. The company's research and development arm further bolsters this, as it brings innovative products to life, enhancing their portfolio with items like specialty plastics and solar energy solutions. Beyond just a chemical company, Kaneka leverages its advanced technological capabilities and keen market insight to stay ahead, making strategic investments and fostering collaboration across industries. This not only solidifies its position in the existing markets but also opens new avenues for growth, ensuring its prominence and profitability in the world stage.